K012777

Substantially Equivalent

ACS: 180 AND ADVIA CENTAUR ANTI-THYROGLOBULIN IMMUNOASSAYS

Applicant: Bayer Corp.
Product code: JZO
Advisory panel: Immunology
Date received: 2001-08-20
Decision date: 2001-10-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.